Luiz Tófoli
Professor in the Department of Psychiatry, Faculty of Medical Sciences, UNICAMP
Data updated
Research Footprint
Luiz Tófoli appears in 24 tracked papers (2015–2023), most studied alongside Ayahuasca, LSD and Ibogaine, across Substance Use Disorders (SUD), Depressive Disorders and Anxiety Disorders.
Most-cited paper: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (814 citations).
Frequent co-authors: Draulio Araújo, Sidarta Ribeiro and Fernanda Palhano-Fontes.
Background & Research
Luiz F. Tófoli is a Brazil-based clinical researcher whose work bridges empirical, qualitative and psychometric approaches within contemporary psychedelic science. Tófoli has contributed to large-scale survey research (including analyses from the Global Ayahuasca Survey) that characterises adverse events, use patterns and wellbeing outcomes among ayahuasca users, and has led or co-authored studies examining subjective experiential reports through quantitative textual and phenomenological methods. He has also investigated the influence of context and setting on ayahuasca outcomes and contributed to the development and review of psychometric instruments for psychedelic research.
In addition to naturalistic and survey work, Tófoli has been involved in clinical and treatment-focused research, including an open-label pilot of MDMA-assisted psychotherapy for victims of sexual abuse with severe PTSD and phenomenological analyses of ibogaine in the context of drug-dependence treatment. His publications emphasise safety profiles, subjective experience, and methodological rigour for studying both therapeutic potential and risks of classic and non-classic psychedelics, with recurrent focus on depressive disorders, PTSD and substance-use disorders.
Key Impact
Notable for empirical and methodological contributions to the study of ayahuasca, ibogaine and early-stage psychedelic-assisted therapies in Brazil, including survey research on adverse effects and pilot clinical work with MDMA-assisted psychotherapy.
Collaboration Network
42 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Luiz Tófoli is associated with.